Profil
Dr. Gregory S.
Wagner is Senior Vice President-Research & Development at Resverlogix Corp.
Dr. Wagner was previously employed as Vice President-PreClinical Development by Galileo Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Iowa, and a doctorate degree from the University of Iowa.
Anciens postes connus de Gregory S. Wagner
Sociétés | Poste | Fin |
---|---|---|
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/01/2006 |
RESVERLOGIX CORP. | Corporate Officer/Principal | - |
Formation de Gregory S. Wagner
University of Iowa | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
RESVERLOGIX CORP. | Health Technology |
Entreprise privées | 1 |
---|---|
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |